Analyst Recommendations

Citigroup analyst issues BUY recommendation for DKL on August 28, 2024 04:47AM ET. The previous analyst recommendation was Neutral.DKL was trading at $38.83 at issue of the analyst...

August 28, 2024   DKL -1.27%

UBS analyst issues SELL recommendation for CLPBY on August 28, 2024 04:38AM ET. CLPBY was trading at $13.88 at issue of the analyst recommendation.The overall analyst consensus :...

August 28, 2024   CLPBY 1.20%

UBS analyst issues BUY recommendation for WILYY on August 28, 2024 04:39AM ET. WILYY was trading at $20.77 at issue of the analyst recommendation.The overall analyst consensus :...

August 28, 2024   CLPBY 1.20%

Summit Insights Group analyst issues HOLD recommendation for SMTC on August 27, 2024 09:27PM ET. The previous analyst recommendation was Buy.SMTC was trading at $38.16 at issue of...

August 27, 2024   SMTC 2.67%

Citigroup analyst issues SELL recommendation for GCI on August 27, 2024 08:40PM ET. The previous analyst recommendation was Neutral.GCI was trading at $5.78 at issue of the analyst...

August 27, 2024   GCI -0.34%

Guggenheim analyst issues BUY recommendation for NBTX on August 27, 2024 06:59PM ET. NBTX was trading at $5.13 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest 10 recommendations

August 27, 2024   NBTX 4.37%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for WGS on August 27, 2024 04:21PM ET. WGS was trading at $35.35 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   WGS -2.32%

Wells Fargo analyst issues UNDERWEIGHT recommendation for MLAB on August 27, 2024 04:19PM ET. MLAB was trading at $140.86 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   MLAB 2.76%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for BIO on August 27, 2024 04:21PM ET. BIO was trading at $319.37 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   BIO 0.37%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for DHR on August 27, 2024 04:23PM ET. The previous analyst recommendation was Overweight.DHR was trading at $268.82 at issue of the...

August 27, 2024   DHR -1.42%